Kwang‐Hyub Han

Researcher Next ID · RN-005737

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Liver Disease Diagnosis and Treatment

Hepatocellular Carcinoma Treatment and Prognosis

Hepatitis B Virus Studies

Hepatitis C virus research

Liver Disease and Transplantation

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)30207-1
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Hepatology International · 2017 · https://doi.org/10.1007/s12072-017-9799-9
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Journal of Hepatology · 2016 · https://doi.org/10.1016/j.jhep.2016.12.022
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00198-9
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa051285

No projects listed.